Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
2.920
+0.030 (1.05%)
Nov 21, 2024, 1:14 PM EST - Market open
Vivos Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Net Income | -12.57 | -13.58 | -23.85 | -20.29 | -12.06 | -10.75 | Upgrade
|
Depreciation & Amortization | 0.59 | 0.62 | 0.67 | 0.73 | 0.72 | 0.75 | Upgrade
|
Other Amortization | - | - | - | - | - | 0.01 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | 0.04 | - | - | 0.06 | Upgrade
|
Stock-Based Compensation | 0.97 | 1.84 | 3.11 | 2.91 | 2.66 | 2.06 | Upgrade
|
Other Operating Activities | 0.23 | -3.69 | -1.27 | 0.88 | 3.43 | -0.01 | Upgrade
|
Change in Accounts Receivable | -0.23 | 0.26 | 0.75 | 0.23 | -0.56 | -0.28 | Upgrade
|
Change in Accounts Payable | -0.45 | 0.73 | 0.49 | 0.14 | -0.27 | 0.55 | Upgrade
|
Change in Unearned Revenue | -1.12 | -0.61 | 0.64 | -0.54 | -0.01 | 2.06 | Upgrade
|
Change in Other Net Operating Assets | 0.09 | 2.49 | -0.16 | 0.2 | 0.41 | 0.2 | Upgrade
|
Operating Cash Flow | -12.5 | -11.95 | -19.59 | -15.74 | -5.68 | -5.34 | Upgrade
|
Capital Expenditures | -0.57 | -0.85 | -0.92 | -2.4 | -0.12 | -0.18 | Upgrade
|
Cash Acquisitions | - | - | - | -0.23 | - | - | Upgrade
|
Divestitures | - | - | - | - | - | 0.25 | Upgrade
|
Other Investing Activities | - | - | - | 0.01 | - | 0.01 | Upgrade
|
Investing Cash Flow | -0.57 | -0.85 | -0.92 | -2.61 | -0.12 | 0.09 | Upgrade
|
Long-Term Debt Issued | - | - | - | - | 1.27 | 3.76 | Upgrade
|
Long-Term Debt Repaid | - | - | - | -0.03 | -0.08 | -0.03 | Upgrade
|
Net Debt Issued (Repaid) | - | - | - | -0.03 | 1.19 | 3.73 | Upgrade
|
Issuance of Common Stock | 19.74 | 12 | - | 27.93 | 22.29 | 1.25 | Upgrade
|
Other Financing Activities | -1.35 | -1.08 | - | -2.24 | -0.25 | -0.16 | Upgrade
|
Financing Cash Flow | 18.39 | 10.92 | - | 24.17 | 23.54 | 4.47 | Upgrade
|
Net Cash Flow | 5.32 | -1.88 | -20.51 | 5.82 | 17.74 | -0.79 | Upgrade
|
Free Cash Flow | -13.07 | -12.8 | -20.51 | -18.13 | -5.8 | -5.52 | Upgrade
|
Free Cash Flow Margin | -89.62% | -92.74% | -128.00% | -107.38% | -44.39% | -48.42% | Upgrade
|
Free Cash Flow Per Share | -3.66 | -10.50 | -22.28 | -21.35 | -11.27 | -11.18 | Upgrade
|
Cash Interest Paid | - | - | - | 0.02 | 0.03 | 0.02 | Upgrade
|
Levered Free Cash Flow | -8.11 | -7.69 | -11.25 | -11.27 | -2.83 | -1.41 | Upgrade
|
Unlevered Free Cash Flow | -8.11 | -7.69 | -11.25 | -11.26 | -2.77 | -1.34 | Upgrade
|
Change in Net Working Capital | 2.16 | -1.51 | -1.54 | 0.34 | 0.58 | -2.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.